Dapagliflozin in Type 2 Diabetes Patients, a Retrospective Cohort Study From Turkey

Clinical trial NCT03407196 · COMPLETED

Trial details

NCT number: NCT03407196
Sponsor: AstraZeneca Turkey
Status: COMPLETED
Study type: OBSERVATIONAL

Type 2 Diabetes Mellitus

Start date: 2017-05-24
Primary completion: 2017-12-31
Enrollment: 1683

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.